Results 1 - 10 of 8021
Results 1 - 10 of 8021. Search took: 0.027 seconds
|Sort by: date | relevance|
[en] Purpose: to develop different prototypes of permanently controllable rotating biopsy devices with determination of the most efficient prototype in biopsies in bovine myocardium. Materials and Methods: Five different prototypes of 18-gauge rotating biopsy devices were designed and constructed, four (1-4) with various drill-like cutting edges and one (5) cannula type with a lancet-like helically bent cutting edge. Using bovine myocardium as the biopsy tissue, n = 100 specimens per prototype were obtained, and a quantitative analysis including tissue fragmentation, length in mm and weight in mg was carried out. For statistical analysis, the chi-square test for tissue fragmentation and Kruskal-Wallis test for the parameters length and weight were calculated. Results: prototype 5 showed the highest rate of extraction of one-fragment specimens in n=66 cases and the lowest rate of failure to obtain tissue in n=11 cases. The mean length/weight were 4.15 mm/3.91 mg for prototype 1, 1.80 mm/1.66 mg for prototype 2, 4.61 mm/3.28 mg for prototype 3, 5.20 mm/3.74 mg for prototype 4, and 9.57 mm/6.97 mg for prototype 5. In all three categories, prototype 5 was significantly superior to the prototypes 1-4 with p < 0.001. Conclusion: the cannula type with a lancet-like helically bent cutting edge proved to be the most efficient prototype and may now be tested competitively against established automated biopsy devices in vitro. (orig.)
[en] Melanoma is the most malignant cutaneous tumor. In the present time, sentinel node biopsy is a standard of care in patients with thickness of primary lesion more than 1 mm. Authors present a case report of a patient after excision of cutaneuos tumor from the right shoulder which was initially histopathologically diagnosed as melanoma in situ. This patient developed after eight years regional supraclavicular and axillary lymphadenopathy, and therefore the histopathological examination of the specimen was revised. This revision classified the primary tumor as a superficial spreading melanoma Breslow 0.9 mm, Clark III with mitotic rate of 5 mitoses/1 mm2. On the basis of the histopathologic finding of metastatic involvement of the supraclavicular lymph node a complete dissection of the right axillary lymph nodes was performed. Metastases were present in all dissected axillary lymph nodes. Authors discuss individual consideration for offering sentinel node biopsy to patients with melanoma of thickness less than 1 mm if risk factors such as mitotic rate equal to or more than 1 mitosis/1 mm2 and ulceration are present. (author)
[en] Recently, it has been shown that transjugular liver biopsy (TJLB) with three passes gives comparable specimens to percutaneous liver biopsy (PLB). The aim of this study was to evaluate the adequacy of TJLB using four passes in a consecutive series of patients, and whether using a supportive cassette can prevent fragmentation. One hundred consecutive TJLBs in 92 patients (48 transplanted), always using four passes (19-G Tru-Cut), were compared to three-pass TJLBs. The four-pass TJLB specimens were randomized at a 1:1 ratio of liver cores placed in a cassette versus not. The four-pass TJLBs, compared to three-pass TJLBs, resulted in better specimens for length (≥25 mm: 50% vs. 35%; p = 0.026) and number of complete portal tracts (CPTs) (≥11: 40% vs. 26%; p = 0.027), without a higher complication rate. The four-pass TJLB with ≥11 CPTs had a median length of 27 mm, and 57% of them longer than 28 mm contained ≥11 CPTs. Putting the liver biopsy cores into a cassette did not improve the fragmentation rate or adequacy of the specimen (length and number of CPTs) of TJLB. We conclude that at least four passes with TJLB should be performed when liver specimens are needed for grading and staging. Using a supportive cassette did not reduce fragmentation.
[en] Fine needle aspiration biopsy (FNAB) is an accurate and cost effective diagnostic tool for differentiating malignant and benign thyroid nodules. Despite the efforts of the Papanicolaou group to standardize thyroid cytopathology reporting, no universal standard reporting system exists to date. Pathologists believe that clinicians sufficiently understand FNAB cytological reports. However, this is not necessarily the case. There is often a significant gap between pathologists' beliefs and the clinicians' understanding. As a result, we propose 'The Bethesda System for Reporting Thyroid Cytopathology' by the National Cancer Institute. In this editorial, we briefly introduce the Bethesda System for Reporting Thyroid Cytopathology
[en] Fibro-osseous lesions of the bone are well-recognized primary bone tumours. However, given the degree of overlap of imaging findings and variation in management of various sub-types, it is a widely accepted practice to perform a biopsy to obtain histopathological confirmation of the diagnosis. The following is a summary of the epidemiology, clinicopathological features, and review of the imaging features of fibro-osseous lesions, including osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma, adamantinoma, and lesions that closely mimic them. The illustrated examples are histologically proven cases that were presented to a tertiary referral teaching hospital and national bone and soft-tissue tumours unit. It is important that all radiologists are aware of the nature and imaging characteristics of these tumour sub-types, so that suspected lesions are recognized and appropriately referred to specialist bone tumour services for work-up and management
[en] A 39-year-old woman presented with a rapidly growing nodule on the right thumb. An ultrasound study demonstrated a mass located in the deep subcutaneous tissue on the ulnar side of the interphalangeal joint. Incisional biopsy yielded the diagnosis of nodular fasciitis. We discuss the ultrasound appearance of nodular fasciitis as reported in the literature and how to make the differential diagnosis of an echogenic finger mass
[en] To provide new US criteria for the indication of fine-needle aspiration biopsy (FNAB) in nonpalpable solid thyroid nodules. The US scans of 155 non-palpable thyroid nodules in 132 subjects were prospectively classified as benign or malignant. Malignant findings included microcalcifications, irregular or microlobulated margin, marked hypoechogenicity and taller than wider shape. If even a single malignant feature was present, the nodule was classified as malignant. If nodules didn't have any malignant features, they were classified as benign. Final diagnosis of benign (n=106) or malignant (n=49) was obtained by means of FNAB and follow-up (>6 months) in 83 benign nodules, by FNAB and surgery in 44 malignant and 15 benign lesions, and by surgery alone in 5 malignant and 8 benign lesions. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy were calculated using our proposed classification method. Considering the high level of sensitivity of our proposed US classification, fine-needle aspiration biopsy should be performed on thyroid nodules classified as malignant category, although nonpalpable.
[en] The purpose of our study was to assess the usefulness of ultrasound determined testicular volume in the evaluation of the infertile men with azoospermia. A computerized search from October 2005 to June 2010 generated a list of 45 infertile men with azoospermia (mean age, 34 years: age range, 26-44 years) who underwent both scrotal ultrasound and testis biopsy. Ultrasound determined testicular volumes were compared between infertile men with obstructive azoospermia and those with non-obstructive azoospermia. Testicular volume for obstructive azoospermia ranged from 6.4 ml to 26.9 ml, with a median volume of 14.0 ml. This volume was significantly larger than that of those with non-obstructive azoospermia, which ranged from 1.0 ml to 12.8 ml, with a median volume of 6.1 ml (p < 0.001). The area under the ROC curve for distinguishing non-obstructive azoospermia from obstructive azoospermia using testicular volume was 0.91. A cutoff value of less than or equal to 11.4 ml could distinguish non-obstructive azoospermia from obstructive azoospermia, with a sensitivity of 94.1% (95% CI; 71.3-99.9%) and a specificity of 73.3% (95% CI; 54.1-87.7%). Ultrasound-determined testicular volume can be helpful in the differentiation of obstructive azoospermia from non-obstructive azoospermia